Financials

  • Market Capitalization 9.93 B
  • Employee 273
  • Founded 2015
  • CEO N/A
  • Website www.kymeratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00SDHC8D1
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-21.09
Fiyat/satışlar oranı
167.66

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
924
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
78.74 USD-1.33%-0.73%-3.36%+98.61%10.02 B USD
929
PRAX
Praxis Precision Medicines, Inc. - Common Stock
347.94 USD-5.41%-8.57%+15.59%+656.06%9.71 B USD
957
PTGX
Protagonist Therapeutics, Inc. - Common Stock
144.03 USD-3.66%-4.92%+5.21%+91.71%9.32 B USD
988
CRNX
Crinetics Pharmaceuticals, Inc. - Common Stock
84.85 USD0.00%+0.15%+1.14%+106.45%9.00 B USD

Haberler